Use of Triple Combination Antiretroviral Therapy With Raltegravir as Empiric HIV Therapy in the High-risk HIV-exposed Newborn

Autor:	Valérie Lamarre, Fatima Kakkar, Marie-Julie Trahan, Marie-Elaine Metras
Rok vydání:	2019
Předmět:	Microbiology (medical) Perinatal transmission Pediatrics medicine.medical_specialty Anti-HIV Agents Population Human immunodeficiency virus (HIV) HIV Infections medicine.disease_cause Chemoprevention Young Adult 03 medical and health sciences 0302 clinical medicine Antiretroviral Therapy Highly Active Raltegravir Potassium 030225 pediatrics Triple combination Humans Medicine 030212 general & internal medicine Young adult education HIV therapy education.field_of_study business.industry Infant Newborn Raltegravir Antiretroviral therapy Infectious Disease Transmission Vertical Infectious Diseases Pediatrics Perinatology and Child Health Female Post-Exposure Prophylaxis business medicine.drug
Zdroj:	Pediatric Infectious Disease Journal. 38:410-412
ISSN:	0891-3668
Popis:	The recent approval of raltegravir granules for suspension in the newborn population offers a new option for the antiretroviral prophylaxis of newborns for the prevention of perinatal transmission. However, there are little data on its use in preterm infants, nor on outcomes following its use as empiric HIV therapy for newborns subsequently found to be infected. We describe here the use of RAL granules for suspension in these cases.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::266b66c18d6b4b19b2c6208d4d3b8cfb https://doi.org/10.1097/inf.0000000000002180 Zobrazit plný text záznamu